--- title: Profil的临床试验患者招募 description: 用于药物和医疗设备试验的Profil Gemany糖尿病患者数据库是广泛且受到精心维护的资源。 --- [![profil-logo-wortbild-with claim-4c-offset_1000px-1](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png?width=1000&name=profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png "profil-logo-wortbild-with claim-4c-offset_1000px-1")](https://www.profil.com?hsLang=zh) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) # [![Header_1077x260px_FurtherServices-1](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_FurtherServices-1.jpg?width=1077&height=260&name=Header_1077x260px_FurtherServices-1.jpg) 患者招募 为临床试验招募患者](https://www.profil.com/zh/services/patient-recruitment#) ## 大型受试者数据库 作为一家临床研究中心，Profil非常清楚糖尿病患者数据库必须范围广泛并且能够保持更新。快速地招募以及选择合适的患者或健康志愿者是成功且及时完成临床试验的关键。 为了确保能够及时招募志愿者，Profil发展出一个拥有超过31,000人的数据库，该数据库包括1型和2型糖尿病患者，以及肥胖和精壮的健康志愿者。 为了满足特定的试验要求，该数据库也可对主要的纳入和排除标准进行筛选，包括但不限于病史、实验室数据和伴随用药（成分和物质类别编码依照世界卫生组织药物词典）。9名专门的招募协调员与潜在的研究对象保持着密切联系，以确保数据库内容的实时更新。 ### 极低的脱落率 遵守时间表不仅仅是要快速地找到受试者。由于所有临床试验的平均脱落率约为30%，因此许多研究被不必要地延期了。在Profil，我们的平均脱落率达到了极低的7.5%（2014-2018年随机分组受试对象），这有助于我们降低成本，使我们能够制定更可靠的研究时间表，并最终为您更快地提供所需结果。 ### 事实与数据 - 数据库拥有>31,000 个有效的受试者条目 > 13,000 名2型糖尿病患者 > 6,000 名1型糖尿病患者 > 11,000 名健康志愿者，包括肥胖人群 - 记录内容包括病史，实验室数据，身高体重指数和伴随用药（根据世界卫生组织药物词典） - 种族：高加索人，日本人，中国人 - 平均脱落率仅为7.5% ![pikto2.png](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_NewWebinar.png?width=62&height=70&name=Icon_NewWebinar.png) ### 试用我们的数据库 您已经拥有了研究大纲？测试一下我们是否能为您的研究招募志愿者。 [![检查研究](https://no-cache.hubspot.com/cta/default/481167/310abcfd-f6a6-458b-ad22-4e784e7be949.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/310abcfd-f6a6-458b-ad22-4e784e7be949) ![Dr. Lars Bochmann](https://www.profil.com/hs-fs/hubfs/Mitarbeiter/Lars_Bochmann.png?width=154&height=176&name=Lars_Bochmann.png) ### 我们的专家 **Lars Bochmann 博士** 市场及业务发展总监   [![与他联系](https://no-cache.hubspot.com/cta/default/481167/aef715f9-ad6f-4a32-80d9-24031ad121c0.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/aef715f9-ad6f-4a32-80d9-24031ad121c0) [![patient_database_split_by_group](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/content-bilder/Patient_Recruitment/patient_database_split_by_group.jpg?width=837&height=780&name=patient_database_split_by_group.jpg) ![enlarge](https://www.profil.com/hubfs/BLUE_MOON/piktos/Lupe-01-1.svg) ](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Patient_Recruitment/patient_database_split_by_group.jpg?hsLang=zh) [![gfx_treatment_distribution](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/content-bilder/Patient_Recruitment/gfx_treatment_distribution.jpg?width=854&height=735&name=gfx_treatment_distribution.jpg) ![enlarge](https://www.profil.com/hubfs/BLUE_MOON/piktos/Lupe-01-1.svg) ](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Patient_Recruitment/gfx_treatment_distribution.jpg?hsLang=zh) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=zh) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Marquard J. et al., 2015. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nature Medicine 21, 363–372 (2015). [View all](https://www.profil.com/knowledge-center/publications?hsLang=zh) Profil has an extensive diabetes patient database that is kept current by a team of dedicated recruitment coordinators. At our in-house clinic, we work to ensure patient compliance with physician’s instructions and clinical trial conditions, so our repeat participants understand the needs of pharmaceutical trials. We have more than 27,000 subjects ready to take part in clinical studies on diabetes and obesity. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=zh) | [Privacy Policy](https://www.profil.com/privacy?hsLang=zh)